20th European Urology
Residents Education Programme
Registration information

Static homepage

Dear future European urologists

On its second successful decade as a comprehensive course, the European Urology Residents Education Programme (EUREP) continues to be a reputable and educative programme for final-year residents.

Organised by the European School of Urology, EUREP is designed to offer a significant overview of urological topics with a high-degree of interaction and brainstorming. Its five modules consist of mornings reserved for state-of-the-art lectures and the afternoons for discussions, videos and test-your-knowledge sessions.

Read more

Dr Evangelos Liatsikos

E. Liatsikos
Chairman ESU

Why you should attend this meeting

Extensive coverage

The EUREP programme is always wide-ranged and dynamic, covering almost the whole spectrum of urology in 6 intensive days; from onco-urology, functional urology, andrology, to paediatric urology.

Best practices and expert faculty

The internationally-known EUREP faculty will guide delegates in modules designed to enrich knowledge and skills, boost daily clinical practice, and address commonly-faced challenges.

Excellent career opportunities

EUREP opens new doors and possibilities for urology residents  that benefit their professional careers, and expand their connections.

News & Reports

European School of Urology on Twitter

Phase 2 RCT: ADT plus local therapy was associated with more favorable radiographic progression-free and overall survival when compared to ADT alone, in men with 1-5 metastatic lesions.

Read more 👇
https://prostate.uroonco.uroweb.org/publication/combination-of-androgen-deprivation-therapy-with-radical-local-therapy-versus-androgen-deprivation-therapy-alone-for-newly-diagnosed-oligometastatic-prostate-cancer-a-phase-ii-randomized-controlled-t/

#prostatecancer

@roodvdb

Offer a PSMA PET scan to men with a persistent PSA > 0.2 ng/ml after radical prostatectomy if the results will influence subsequent treatment decisions.

#ProstateCancer #EAUguidelines

https://uroweb.org/guidelines/prostate-cancer

Only the highest risk patients with adverse pathology after #prostatectomy have benefit of adjuvant radiotherapy versus early salvage.

Read more 👇
https://prostate.uroonco.uroweb.org/publication/not-all-adverse-pathology-features-are-equal-identifying-optimal-candidates-for-adjuvant-radiotherapy-among-patients-with-adverse-pathology-at-radical-prostatectomy/

#prostatecancer

@elio_mazzone @GGandaglia @SimoneScuderi1 @DanieleRaggi83 @AndreaNecchi @roodvdb

#EAU22 In this new edition of the @EAU_Uroonco we discuss on mHSPC using a real world case @delataillealex present the results of the ARASENS Trial and @EfstathiouEleni gives her state-of-the-art lecture on mHSPC combination therapy. Moderated by @MRoupret http://prostate.uroonco.uroweb.org/video/esou-online-eau22-highlights-in-prostate-cancer/?utm_source=Topic+Oncology&utm_campaign=8c82796c59-EMAIL_CAMPAIGN_2018_11_27_02_56_COPY_01&utm_medium=email&utm_term=0_df6d42a99e-8c82796c59-107752505

@EUplatinum Can We Measure the Academic Impact of SoMe? SoMe is here to stay, and thus 👨🏾‍🎓👨‍🏫 should embrace it. However, there are still gaps: how it can be quantified using alternatives📈, and how to apply these novel metrics to a curricular point of view https://www.sciencedirect.com/science/article/pii/S0302283822024769?dgcid=author

Load More...